SCHEMBL30233448

SCHEMBL30233448

C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.60
▸ APLNR P35414 2/20 0.56
▸ CXCR4 P61073 2/20 0.54
▸ CALCR P30988 5/20 0.54
▸ MC4R P32245 1/20 0.54
▸ NMUR2 Q9GZQ4 2/20 0.53
▸ NMUR1 Q9HB89 2/20 0.53
▸ RAMP3 O60896 1/20 0.53
▸ EPHA2 P29317 1/20 0.52
▸ HCRTR1 O43613 1/20 0.52
▸ HCRTR2 O43614 1/20 0.52
▸ OPRM1 P35372 1/20 0.52
▸ OPRD1 P41143 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29843099 0.98 C5AR1 (0.58) C5AR1APLNRCXCR4CALCRMC4R
SCHEMBL30753760 0.95 C5AR1 (0.64) C5AR1APLNRCXCR4CALCRMC4R
SCHEMBL30233281 0.94 C5AR1 (0.63) C5AR1APLNRCXCR4CALCRMC4R
SCHEMBL30233565 0.94 C5AR1 (0.59) C5AR1APLNRCXCR4CALCRMC4R
SCHEMBL30788369 0.93 C5AR1 (0.57) C5AR1APLNRCXCR4MC4ROPRM1
SCHEMBL30788366 0.92 C5AR1 (0.58) C5AR1APLNRCXCR4MC4ROPRM1
SCHEMBL30233460 0.92 CALCR (0.59) C5AR1CALCRHCRTR1HCRTR2OPRM1
SCHEMBL30788357 0.91 TFPI (0.59) C5AR1CXCR4CALCRMC4RHCRTR1
SCHEMBL30233748 0.91 C5AR1 (0.59) C5AR1APLNRCXCR4CALCRMC4R
SCHEMBL30233422 0.91 C5AR1 (0.58) C5AR1APLNRCXCR4CALCRNMUR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115702161-A Peptide compositions and methods for inhibiting nicotinic acetylcholine receptor activity 格罗制药公司 2023-02-14 — — CN disclosed
Send feedback